ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Neurology Prescribers in South Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CAROL KOOISTRA MD

Neurology

11,759

$2.01M

818
346 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$171
Average prescription price

Avg: $214

JULIETTE SAAD MD

Neurology

9,104

$2.37M

610
269 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$261
Average prescription price

Avg: $214

HOWARD MANDELL M.D.

Neurology

8,375

$1.69M

673
412 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$202
Average prescription price

Avg: $214

KENT KISTLER MD

Neurology

6,098

$1.08M

722
496 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$177
Average prescription price

Avg: $214

ORLANDO RICALDE M.D.

Neurology

5,871

$780K

430
250 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$133
Average prescription price

Avg: $214

BOGDAN GHEORGHIU M.D.

Neurology

5,724

$850K

613
378 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$148
Average prescription price

Avg: $214

ELEANYA OGBURU-OGBONNAYA M.D.

Neurology

5,480

$840K

271
38 are 65+

74%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 25%

$153
Average prescription price

Avg: $214

JOHN ABSHER M.D.

Neurology

5,467

$1.34M

739
399 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

2%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 25%

$246
Average prescription price

Avg: $214

ALLAN RYDER-COOK M.D.

Neurology

5,358

$1.19M

516
308 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$222
Average prescription price

Avg: $214

JEFF BENJAMIN DO

Neurology

5,146

$1.71M

555
354 are 65+

15%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 25%

$333
Average prescription price

Avg: $214

DAVID ROGERS M.D.

Neurology

5,039

$608K

496
202 are 65+

62%
patients receiving schedule two controlled substances

Avg: 5%

29%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$121
Average prescription price

Avg: $214

CAROL NICHOLS MD

Neurology

4,939

$613K

399
163 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$124
Average prescription price

Avg: $214

DIXON CUNNINGHAM MD

Neurology

4,639

$1.18M

513
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$255
Average prescription price

Avg: $214

BRET WARNER MD

Neurology

4,533

$558K

435
253 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$123
Average prescription price

Avg: $214

MICHAEL MARESKA M.D.

Neurology

4,499

$920K

374
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$205
Average prescription price

Avg: $214

JAMES CARNES M.D.

Neurology

4,414

$1.31M

488
258 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$297
Average prescription price

Avg: $214

MICHAEL MCCAFFREY MD

Neurology

3,834

$900K

463
278 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 25%

$235
Average prescription price

Avg: $214

GEORGE BAXLEY MD

Neurology

3,771

$758K

330
146 are 65+

15%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$201
Average prescription price

Avg: $214

GONZALO PARES M.D.

Neurology

3,651

$315K

178
64 are 65+

32%
patients receiving schedule two controlled substances

Avg: 5%

35%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$86
Average prescription price

Avg: $214

THOMAS FOX MD

Neurology

3,561

$669K

347
201 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 25%

$188
Average prescription price

Avg: $214

MELVYN HAAS MD

Neurology

3,447

$405K

283
224 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$117
Average prescription price

Avg: $214

MOHAMMED ALHATOU M.D.

Neurology

3,446

$537K

472
239 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 5%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$156
Average prescription price

Avg: $214

JOHN PILCH M.D.

Neurology

3,407

$483K

408
288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$142
Average prescription price

Avg: $214

CHARLES SHISSIAS M.D.

Neurology

3,230

$540K

402
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 25%

$167
Average prescription price

Avg: $214

ROLAND SKINNER MD

Neurology

3,224

$655K

350
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 25%

$203
Average prescription price

Avg: $214

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank